DNA replication licensing is associated with resistance to CDK4/6 inhibitors in ER-positive breast cancer

被引：0
作者：
Nanda, Sarmistha
Shea, Martin J.
Schiff, Rachel
Osborne, C. Kent
Rimawi, Mothaffar
Fu, Xiaoyong
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P2-03-10
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-03-10
引用
收藏
页数：2
相关论文
共 50 条
[41]   Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment [J].
Glaviano, Antonino ;
Wander, Seth A. ;
Baird, Richard D. ;
Yap, Kenneth C. -H. ;
Lam, Hiu Yan ;
Toi, Masakazu ;
Carbone, Daniela ;
Geoerger, Birgit ;
Serra, Violeta ;
Jones, Robert H. ;
Ngeow, Joanne ;
Toska, Eneda ;
Stebbing, Justin ;
Crasta, Karen ;
Finn, Richard S. ;
Diana, Patrizia ;
Vuina, Karla ;
de Bruin, Robertus A. M. ;
Surana, Uttam ;
Bardia, Aditya ;
Kumar, Alan Prem .
DRUG RESISTANCE UPDATES, 2024, 76
[42]   Inhibition of CDK7 overcomes resistance to CDK4/6 inhibitors in hormone receptor positive breast cancer cells [J].
Guarducci, C. ;
Nardone, A. ;
Feiglin, A. ;
Migliaccio, I. ;
Malorni, L. ;
Bonechi, M. ;
Benelli, M. ;
Di Leo, A. ;
Hodgson, G. ;
Shapiro, G. ;
Brown, M. ;
Jeselsohn, R. .
CANCER RESEARCH, 2019, 79 (04)
[43]   Triple combination targeting PI3K, ER, and CDK4/6 inhibits growth of ER-positive breast cancer resistant to fulvestrant and CDK4/6 or PI3K inhibitor [J].
Karimi, Leena ;
Alves, Carla L. ;
Terp, Mikkel G. ;
Tuttolomondo, Martina ;
Portman, Neil ;
Ehmsen, Sidse ;
Johansen, Lene E. ;
Bak, Martin ;
Lim, Elgene ;
Ditzel, Henrik J. .
CANCER COMMUNICATIONS, 2023, 43 (06) :720-725
[44]   CDK4/6 inhibitors in advanced hormone receptor-positive breast cancer [J].
Barroso-Sousa, Romualdo ;
Tolaney, Sara M. .
TRANSLATIONAL CANCER RESEARCH, 2017, 6 :S205-S209
[45]   Carboxypeptidase vitellogenic like facilitates resistance to CDK4/6 inhibitors in breast cancer [J].
Zhu, Xiang ;
Xu, Xiaojie ;
Zhang, Lin ;
Yang, Xuhui .
THORACIC CANCER, 2023, 14 (11) :983-991
[46]   Inhibition of 3-phosphoinositide dependent protein kinase 1 (PDK1) synergizes with CDK4/6 inhibitors against ER-positive breast cancer [J].
Jansen, V. M. ;
Bhola, N. E. ;
Bauer, J. A. ;
Formisano, L. ;
Moore, P. ;
Koch, J. ;
Arteaga, C. L. .
CANCER RESEARCH, 2016, 76
[47]   Improving Breast Cancer Therapy With CDK4/6 Inhibitors [J].
Jaganathan, Hamsa ;
Overstreet, Karen ;
Reed, Elizabeth .
CLINICAL BREAST CANCER, 2014, 14 (06) :379-380
[48]   Predicting Response to CDK4/6 Inhibitors in Breast Cancer [J].
Schultz, Emily ;
Hamilton, Deanna ;
Wang, Jianxin ;
Witkiewicz, Agnieszka .
LABORATORY INVESTIGATION, 2023, 103 (03) :S208-S208
[49]   CDK4/6 inhibitors in breast cancer: spotting the difference [J].
Perez-Garcia, Jose Manuel ;
Cortes, Javier ;
Llombart-Cussac, Antonio .
NATURE MEDICINE, 2021, 27 (11) :1868-1869
[50]   CDK4/6 inhibitors: mechanisms of resistance and potential biomarkers of responsiveness in breast cancer [J].
Cetin, Bulent ;
Wabl, Chiara A. ;
Gumusay, Ozge .
FUTURE ONCOLOGY, 2022, 18 (09) :1143-1157
12345